Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Sex differences in animal models for cardiovascular diseases and the role of estrogen.

Mahmoodzadeh S, Fliegner D, Dworatzek E.

Handb Exp Pharmacol. 2012;(214):23-48. doi: 10.1007/978-3-642-30726-3_2. Review.

PMID:
23027444
2.

Modulation of cardiac hypertrophy by estrogens.

Pelzer T, Shamim A, Wölfges S, Schumann M, Neyses L.

Adv Exp Med Biol. 1997;432:83-9. Review.

PMID:
9433514
3.

Why sex matters: the biological mechanisms of cardiovascular disease.

Vassalle C, Simoncini T, Chedraui P, Pérez-López FR.

Gynecol Endocrinol. 2012 Sep;28(9):746-51. doi: 10.3109/09513590.2011.652720. Epub 2012 Feb 14. Review.

PMID:
22329808
4.

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.

Bernardo BC, Weeks KL, Pretorius L, McMullen JR.

Pharmacol Ther. 2010 Oct;128(1):191-227. doi: 10.1016/j.pharmthera.2010.04.005. Epub 2010 May 12. Review.

PMID:
20438756
5.

Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.

Kilić A, Javadov S, Karmazyn M.

J Mol Cell Cardiol. 2009 Mar;46(3):360-9. doi: 10.1016/j.yjmcc.2008.11.018. Epub 2008 Dec 10.

PMID:
19111554
6.

Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury.

Murphy E, Steenbergen C.

Cardiovasc Res. 2007 Aug 1;75(3):478-86. Epub 2007 Apr 4. Review.

7.

Gender determinants of cardiovascular risk factors and diseases.

Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, Rosano GM.

J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):207-20. doi: 10.2459/JCM.0b013e32833178ed.

PMID:
19829128
8.

Sex-specific pathways in early cardiac response to pressure overload in mice.

Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, Tiemann K, Stypmann J, Roepcke S, Brokat S, Mahmoodzadeh S, Brozova E, Davidson MM, Ruiz Noppinger P, Grohé C, Regitz-Zagrosek V.

J Mol Med (Berl). 2008 Sep;86(9):1013-24. doi: 10.1007/s00109-008-0385-4. Epub 2008 Jul 30.

9.
10.

Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.

Gillies GE, McArthur S.

Horm Behav. 2010 Jan;57(1):23-34. doi: 10.1016/j.yhbeh.2009.06.002. Epub 2009 Jun 16. Review.

PMID:
19538962
11.

Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms.

Du XJ, Fang L, Kiriazis H.

Pharmacol Ther. 2006 Aug;111(2):434-75. Epub 2006 Jan 24. Review.

PMID:
16439025
12.

Update on cardiovascular disease in post-menopausal women.

Gorodeski GI.

Best Pract Res Clin Obstet Gynaecol. 2002 Jun;16(3):329-55. Review.

PMID:
12099666
13.

Actions of estrogen and estrogen receptors in nonclassical target tissues.

Murphy E, Korach KS.

Ernst Schering Found Symp Proc. 2006;(1):13-24. Review.

PMID:
17824169
14.

Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy.

Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, Mao L, Rockman HA, Korach KS, Murphy E.

Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H469-76. Epub 2004 Sep 16.

15.

Role of the estrogen/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy.

Kararigas G, Fliegner D, Gustafsson JÅ, Regitz-Zagrosek V.

Physiol Genomics. 2011 Apr 27;43(8):438-46. doi: 10.1152/physiolgenomics.00199.2010. Epub 2011 Feb 15.

16.

Sex and gender differences in myocardial hypertrophy and heart failure.

Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R.

Circ J. 2010 Jul;74(7):1265-73. Epub 2010 Jun 15. Review.

17.

Estrogen and cytokines production - the possible cause of gender differences in neurological diseases.

Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I.

Curr Pharm Des. 2005;11(8):1017-30. Review.

PMID:
15777251
18.

Gender modulates cardiac phenotype development in genetically modified mice.

Du XJ.

Cardiovasc Res. 2004 Aug 15;63(3):510-9. Review.

19.

Where do we currently stand with advice on hormone replacement therapy for women?

Bozkurt B.

Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan;6(4):21-5. Review.

PMID:
21088655
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk